pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 8·1 min read
save

Aging scientific workforce grapples with rising fabricated citations as hantavirus cruise ship outbreak drags on

May 8, 2026·read at STAT ↗Neutral

A new analysis highlights that an increasingly senior scientific workforce is coinciding with a surge in fabricated citations across medical journals, raising concerns about research integrity.

The ongoing hantavirus outbreak aboard the cruise ship MV Hondius remains unresolved. WHO officials report the vessel is now heading toward the Canary Islands while teams work to evacuate passengers and crew.

The newsletter also notes the recent departure of several former FDA officials, adding to broader discussions about regulatory leadership and health policy.

These topics were featured in the latest Morning Rounds health briefing, which aggregates current developments for professionals in the field.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “The aging scientific workforce collides with rising fabricating citations in medical journals”

read at STAT ↗
1,055 words · retrieved May 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING4Emory UniversityPATH
drugs
MIFEPRISTONE

related stories

  • Sep 15FDA launches pilot program to speed up early US drug researchBioPharma Dive
  • Sep 11Novartis’ board faces investor scrutiny after M&A misfires and R&D flopsBioSpace
  • Sep 4Biotech is back, with H1 progress smoothing glide path through end of year: TruistBioSpace
  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 25How Trump’s cuts are reshaping America’s health systemSTAT